Weight Loss Drug Belviq Pulled From Shelves After FDA Warns of Cancer Risk

Published Feb 14, 2020

Weight Loss Drug Belviq Pulled From Shelves After FDA Warns of Cancer Risk

A study designed to rule out heart-risk found a slightly higher incidence of cancer among those who took the drug for one year.

NOW
PLAYING
Community Medical Center Shutting Out New Patients Due to COVID Clusters
NOW
PLAYING
"A Second Opportunity at Life"-- Maribel Ramos Is Thriving 5 Years After Experimental Immunotherapy for Triple-Negative Breast Cancer
NOW
PLAYING
Former Senator Bob Dole, 97, Has Lung Cancer-- After His Prostate Cancer, He Helped Remove the Stigma of Erectile Dysfunction
NOW
PLAYING
Singer Alicia Keys' Tips for Staying Centered is Advice All Cancer Patients Should Make Note Of
NOW
PLAYING
The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene Mutation--Extraordinary Results With Sotorasib
NOW
PLAYING
A Husband Learns How to Care for His Wife After Her Ovarian Cancer Diagnosis

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.